Hand-foot genital syndrome affects the development of the hands and feet, the urinary tract, and the reproductive system. Some women with this disorder could be at increased risk of pregnancy loss ...

Anywhere from 45 to 68.3 percent of people on the chemotherapy drug capecitabine develop hand-foot syndrome, according to an article published in the Cancer Investigation Journal in 2002.

Hand-foot-and-mouth disease (HFMD) is commonly caused by coxsackie virus A16, a member of the enterovirus family. In some cases can be caused by the coxsackie B or the enterovirus 71 virus.

One of the side effects of certain types of chemotherapy or biological therapy drugs can be hand-foot syndrome, which is also known as Palmar-Plantar erythrodysesthesia.

Palmar-Plantar Erythrodysesthesia, also called hand-foot syndrome,is a side effect which can occur with several types of chemotherapy or biologic therapy drugs used to treat cancer.

Results: Of 770 pts, 179 (23%) developed any-grade HFS, compared with 591 (77%) who did not. Most instances of HFS (63%) initially occurred during the first 3 treatment cycles. Pts who developed HFS ...

Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study Authors: Yoon-Koo Kang ...

Hand-foot syndrome (HFS), or palmoplantar erythrodysesthesia, is a dermatological toxicity produced by the fluoropyrimidine chemotherapy agents capecitabine and fluorouracil and affects 43-71% of ...

Hand-foot syndrome (HFS), or palmoplantar erythrodysesthesia, is a dermatological toxicity produced by the fluoropyrimidine chemotherapy agents capecitabine and fluorouracil and affects 43-71% of ...